Joint meeting of the Israeli Immunological Society (IIS) and Israeli Society for Cancer Research (ISCR)

The Future of Automating and Commercializing Autologous Cell Therapies

Eytan Abraham
Personalized Medicine, Lonza, Israel

TBC









Powered by Eventact EMS